GBA1 and Parkinson disease: In patients with Parkinson’s disease (PD), particularly those with the PD-GBA1 subtype, alterations in DNA methylation at specific CpG sites within the intron 1 region of the alpha-synuclein (SNCA) gene have been observed, with more pronounced changes in the frontal cortex.